Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood transfusion.

P L Mollison1, P Engelfriet

  • 1University of London, UK.

Seminars in Hematology
|December 14, 1999
PubMed
Summary
This summary is machine-generated.

Blood transfusions are safer due to blood group discovery and anticoagulants. Component therapy and molecular biology advancements have improved safety and efficacy in modern blood transfusions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing ischaemic stroke in six European countries. The EuroHOPE register study.

European journal of neurology·2014
Same author

The Application of Present Knowledge about the Rh Factor.

Postgraduate medical journal·2011
Same author

The survival of transfused erythrocytes in haemolytic disease of the newborn.

Archives of disease in childhood·2010
Same author

Blood groups of Burmese.

Nature·2010
Same author

Observations on cases of starvation at Belsen.

British medical journal·2010
Same author

Treatment of Anaemia by Transfusion of Concentrated Suspensions of Red Cells.

British medical journal·2010
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
Same journal

Evolving insights into mitochondrial presence in RBC in sickle cell disease: Red blood cell and reticulocyte pathophysiology, therapeutic strategies, and future directions.

Seminars in hematology·2026
See all related articles

Area of Science:

  • Immunology
  • Hematology
  • Molecular Biology

Background:

  • Blood transfusions evolved from whole blood to component therapy.
  • Discovery of blood groups and citrate anticoagulants revolutionized transfusion safety.
  • Understanding blood antigens and their genetic basis is crucial.

Observation:

  • Transfusion can trigger antibody formation against donor antigens.
  • Viruses like HIV and hepatitis can be transmitted via transfusion.
  • Molecular biology has identified specific antigens and genes.

Findings:

  • Modern transfusions focus on specific blood components, not whole blood.
  • Characterization of antigens and genes has refined transfusion practices.
  • Significant progress has been made in preventing transfusion-transmitted infections.

Related Experiment Videos

Implications:

  • Component therapy offers targeted treatment for deficiencies.
  • Advanced understanding of immunology and genetics enhances transfusion safety.
  • Continued scientific advancements promise even safer transfusion practices.